EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparison of feline and human immunodeficiency virus reverse transcriptase enzymes through chemical screening and computational analysis

Phanicha Thammajong, Thitinan Aiebchun, Kanokthip Boonyarattanakalin, Duangkamol Gleeson, Nattakarn Pobsuk, Supa Hannongbua, Kiattawee Choowongkomon iD, M Paul Gleeson iD

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.14530 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Phanicha Thammajong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, School of Engineering, King Mongkut's Institute of Technology Ladkrabang, Bangkok, Thailand. Hauptthemen laut MEDLINE: Reverse Transcriptase Inhibitors, Immunodeficiency Virus, Feline, HIV Reverse Transcriptase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Research Council of Thailand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Feline immunodeficiency virus (FIV) is a common infection found in domesticated and wild cats worldwide. Despite the wealth of therapeutic understanding of the disease in humans, considerably less information exists regarding the treatment of the disease in felines. Current treatment relies on drugs developed for the related human immunodeficiency virus (HIV) and includes compounds of the popular non‐nucleotide reverse transcriptase (NNRTI) class. This is despite FIV‐RT being only 67% similar to HIV‐1 RT at the enzyme level, increasing to 88% for the allosteric pocket targeted by NNRTIs. The goal of this project was to try to quantify how well the more extensive pharmacological knowledge available for human disease translates to felines. To this end we screened known NNRTIs and 10 diverse pyrimidine analogs identified virtually. We use this chemo‐centric probe approach to (a) assess the similarity between the two related RT targets based on the observed experimental inhibition values, (b) try to identify more potent inhibitors at FIV, and (c) gain a better appreciation of the structure–activity relationships (SAR). We found the correlation between IC 50 s at the two targets to be strong ( r 2 = 0.87) and identified compound 1 as the most potent inhibitor of FIV with IC 50 of 0.030 μM ± 0.009. This compared to FIV IC 50 values of 0.22 ± 0.17 μM, 0.040 ± 0.010 μM and >160 μM for known anti HIV‐1 RT drugs Efavirenz, Rilpivirine, and Nevirapine, respectively. This knowledge, along with an understanding of the structural origin that give rise to any differences could improve the way HIV drugs are repurposed for FIV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reverse Transcriptase InhibitorsImmunodeficiency Virus, FelineHIV Reverse TranscriptaseAnimalsCatsHumansStructure-Activity RelationshipPyrimidinesAlkynesHIV-1CyclopropanesMolecular Docking SimulationBenzoxazines

Stichwörter der Autor:innen

FIVHIV‐1 RTbiochemical screeningcheminformaticssynthesis

Substanzen

Reverse Transcriptase InhibitorsHIV Reverse TranscriptasePyrimidinesAlkynesreverse transcriptase, Human immunodeficiency virus 1CyclopropanesBenzoxazines

Autor:innen und Institutionen

  • Department of Biomedical Engineering, School of Engineering, King Mongkut's Institute of Technology Ladkrabang, Bangkok, Thailand.
  • Department of Biochemistry, Faculty of Science, Kasetsart University, Bangkok, Thailand.
  • College of Materials Innovation and Technology, King Mongkut's Institute of Technology Ladkrabang, Bangkok, Thailand.
  • Department of Chemistry & Applied Computational Chemistry Research Unit, School of Science, King Mongkut's Institute of Technology Ladkrabang, Bangkok, Thailand.
  • Department of Chemistry, Faculty of Science, Kasetsart University, Bangkok, Thailand.

ORCID-Profile: Kiattawee Choowongkomon, M Paul Gleeson

Förderung

  • National Research Council of Thailand

Zitieren

APA

Thammajong, P., Aiebchun, T., Boonyarattanakalin, K., Gleeson, D., Pobsuk, N., Hannongbua, S., Choowongkomon, K., & Gleeson, M. P. (2024). Comparison of feline and human immunodeficiency virus reverse transcriptase enzymes through chemical screening and computational analysis. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14530

Vancouver

Thammajong P, Aiebchun T, Boonyarattanakalin K, Gleeson D, Pobsuk N, Hannongbua S, et al. Comparison of feline and human immunodeficiency virus reverse transcriptase enzymes through chemical screening and computational analysis. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14530

BibTeX
@article{Thammajong2024,
  author = {Thammajong, Phanicha and Aiebchun, Thitinan and Boonyarattanakalin, Kanokthip and Gleeson, Duangkamol and Pobsuk, Nattakarn and Hannongbua, Supa and Choowongkomon, Kiattawee and Gleeson, M Paul},
  title = {Comparison of feline and human immunodeficiency virus reverse transcriptase enzymes through chemical screening and computational analysis},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.14530}
}
Kostenlos starten →